PARIS (AFP) – Clinical trials of a preventative vaccine for
the Ebola virus made by British pharma company
GlaxoSmithKline may begin next month and made available
by 2015, the World Health Organization said on Saturday.
“We are targeting September for the start of clinical trials,
first in the United States and certainly in African countries,
since that’s where we have the cases,” Jean-Marie Okwo
Bele, the WHO’s head of vaccines and immunisation, told
French radio.
He said he was optimistic about making the vaccine
commercially available. “We think that if we start in
September, we could already have results by the end of the
year.
“And since this is an emergency, we can put emergency
procedures in place … so that we can have a vaccine
available by 2015.”
There is currently no available cure or vaccine for Ebola, a
virus that causes severe fever and, in the worst cases,
unstoppable bleeding.
It has claimed close to 1,000 lives in the latest epidemic to
spread across west Africa this year. Fatality rates can
approach 90 percent, although the latest outbreak has killed
around 55 to 60 percent of those infected.
Several vaccines are being tested, and a treatment made by
San Diego-based Mapp Biopharmaceutical, ZMapp, has
shown promising results on monkeys and may have been
effective in treating two Americans recently infected in
Africa.

Source:
www.vanguardngr.com/2014/08/clinical-trials-ebola-vaccine-start-next-month-may-ready-2015/

May it be a success.

2015!!!!!! This guys really want the population of the black race to decline. we need it like yesterday!

Let it come fast Ooº°
But wait!!!! 2015?? Now that's a serious issue